FOLH1 and colorectal cancer: Building on our prior studies demonstrating the cytotoxic potential of [64Cu]Cu-NOTA-TP in colorectal cancer models [25,26], we designed a novel radiotheranostic agent linking a PSMA-targeting ligand to a 64Cu-radiolabeled TP moiety, a DNA-affinic metal-binding group.